Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

Share Price is delayed by 15 minutes
Get Live Data
13,625.00    95.00 (0.70%)
Bid:
13,580.00
Ask:
13,590.00
Spread: 10.00 (0.074%)
Market Cap: £15.55b
NXT Live PriceLast checked at - London Stock Exchange

Intraday Next Share Chart

Update on Outstanding Notes and RCF

18 Jul 2025 14:17

RNS Number : 7203R
Next PLC
18 July 2025
 

18 July 2025

 

NEXT plc

 

Update on Outstanding Notes and RCF

 

 

NEXT plc announces that:

 

on 17 July 2025, NEXT Group plc (the "Issuer") issued £300,000,000 5.000 per cent. Notes due 2031 (ISIN: XS3116723712) (the "2031 Notes") unconditionally and irrevocably guaranteed by NEXT plc (the "Guarantor") under the Issuer's £3,000,000,000 Euro Medium Term Note Programme;

 

on 17 July 2025, the Issuer used part of the issuance proceeds of the 2031 Notes to purchase an aggregate nominal amount of £136,430,000 of its £250,000,000 4.375 per cent. Bonds due 2026 guaranteed by the Guarantor (ISIN: XS0975833319);

 

as at 18 July 2025, the outstanding nominal amount of all notes issued by the Issuer and guaranteed by the Guarantor is:

 

o £250,000,000 3.000 per cent. Bonds due 2025 (ISIN: XS1985037974), maturing on 26 August 2025;

 

o £113,570,000 4.375 per cent. Bonds due 2026 (ISIN: XS0975833319), maturing on 2 October 2026;

 

o £300,000,000 3.625 per cent. Bonds due 2028 (ISIN: XS1410414954), maturing on 18 May 2028; and

 

o £300,000,000 5.000 per cent. Notes due 2031 (ISIN: XS3116723712), maturing on 17 July 2031; and

 

on 11 April 2025, NEXT Group plc increased the available commitments under its revolving credit facility (the "RCF") by £100,000,000 to an aggregate amount of £525,000,000, which, as at the date of this announcement, remains undrawn, bringing the total amount of available commitments under the RCF and the outstanding notes to £1,488.57m.

 

 

Important Information

 

This Announcement does not constitute, or form part of, any offer or any solicitation of an offer to acquire or subscribe for any shares, bonds or any other securities, nor shall it (or any part of it) or the fact of its dissemination form the basis of, or be relied on in connection with, any contract with respect thereto.

 

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (THE UNITED STATES) OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE OR TO WHOM IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFLVDIITLIE
Date   Source Headline
22nd Mar 20249:15 amRNSDirector Declaration
21st Mar 20241:15 pmRNSDirector Declaration
21st Mar 202412:50 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNEXT plc Results for the Year Ended January 2024
1st Mar 20249:00 amRNSTotal Voting Rights
19th Feb 20242:27 pmRNSClosed Period Share Repurchase Programme
15th Feb 20244:58 pmRNSTransaction in Own Shares
6th Feb 20245:12 pmRNSTransaction in Own Shares
2nd Feb 20245:10 pmRNSTransaction in Own Shares
1st Feb 20245:20 pmRNSTransaction in Own Shares
1st Feb 20248:00 amRNSTotal Voting Rights
23rd Jan 20245:17 pmRNSTransaction in Own Shares
23rd Jan 20242:44 pmRNSDirector Appointment
22nd Jan 20245:41 pmRNSTransaction in Own Shares
17th Jan 20243:48 pmRNSDirector/PDMR Shareholding - Replacement
17th Jan 202412:00 pmRNSDirector Appointment
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTrading Statement
2nd Jan 20248:00 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
4th Dec 202310:45 amRNSDirector/PDMR Shareholding
4th Dec 202310:34 amRNSDirector/PDMR Shareholding
1st Dec 20238:00 amRNSTotal Voting Rights
14th Nov 20234:57 pmRNSHolding(s) in Company
13th Nov 202312:30 pmRNSAGM Update
1st Nov 20238:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTrading Statement
19th Oct 20234:00 pmRNSDirector/PDMR Shareholding
18th Oct 20233:00 pmRNSNew Issue and Additional Listing
13th Oct 20233:11 pmRNSAcquisition of FatFace
3rd Oct 20233:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSBoard Changes
2nd Oct 20238:30 amRNSTotal Voting Rights
25th Sep 20235:15 pmRNSDirector/PDMR Shareholding
25th Sep 20235:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20234:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSResults for the Half Year Ending July 2023
1st Sep 202312:00 pmRNSTotal Voting Rights
1st Sep 20239:30 amRNSAcquisition of Warburg Pincus’ Interest in Reiss
4th Aug 20234:07 pmRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading Statement
1st Aug 20238:34 amRNSTotal Voting Rights
12th Jul 20235:08 pmRNSTransaction in Own Shares
11th Jul 20235:46 pmRNSTransaction in Own Shares
10th Jul 20235:14 pmRNSTransaction in Own Shares
7th Jul 20235:10 pmRNSTransaction in Own Shares
6th Jul 20235:44 pmRNSTransaction in Own Shares
5th Jul 20235:43 pmRNSTransaction in Own Shares
4th Jul 20235:18 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.